Team:Hong Kong HKUST

From 2013.igem.org

(Difference between revisions)
Line 1: Line 1:
-
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.1//EN"
 
-
  "http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd">
 
<html>
<html>
<head>
<head>
-
<h1style="height:420px;background:#fff7e8;margin:0px;padding:0px"></h1>
 
<script src="http://ajax.googleapis.com/ajax/libs/jquery/1.10.2/jquery.min.js">
<script src="http://ajax.googleapis.com/ajax/libs/jquery/1.10.2/jquery.min.js">
</script>
</script>
 +
 +
<script type="text/javascript" src="https://static.igem.org/mediawiki/2013/archive/9/91/20130919145948%21Slide_Show.txt"></script>
 +
 +
<script type="text/javascript">
 +
 +
$(function(){
 +
 +
$("#Slideshow").infiniteCarousel();
 +
 +
});
 +
 +
</script>
 +
<script type="text/javascript">
<script type="text/javascript">
$(document).ready(function(){
$(document).ready(function(){
Line 12: Line 22:
});
});
});
});
-
</script>
+
</script>
 +
 
 +
 
 +
 
<script>
<script>
-
$(document).ready(function()
+
  $(document).ready(function()
   {
   {
-
  $("#team1").mouseover(function(){
 
-
    $("#team1").fadeTo("fast",0.9);
 
-
  });
 
-
  $("#team1").mouseleave(function(){
 
-
    $("#team1").fadeTo("fast", 1);
 
-
  });
 
-
  $("#wetlab1").mouseover(function(){
 
-
    $("#wetlab1").fadeTo("fast",0.9);
 
-
  });
 
-
  $("#wetlab1").mouseleave(function(){
 
-
    $("#wetlab1").fadeTo("fast", 1);
 
-
  });
 
-
  $("#hp1").mouseover(function(){
 
-
    $("#hp1").fadeTo("fast",0.9);
 
-
  });
 
-
  $("#hp1").mouseleave(function(){
 
-
    $("#hp1").fadeTo("fast", 1);
 
-
  });
 
-
  $("#project1").mouseover(function(){
 
-
    $("#project1").fadeTo("fast",0.9);
 
-
  });
 
-
  $("#project1").mouseleave(function(){
 
-
    $("#project1").fadeTo("fast", 1);
 
-
  });
 
-
  $("#achieve1").mouseover(function(){
 
-
    $("#achieve1").fadeTo("fast",0.9);
 
-
  });
 
-
  $("#achieve1").mouseleave(function(){
 
-
    $("#achieve1").fadeTo("fast", 1);
 
-
  });
 
-
  $("#parts1").mouseover(function(){
 
-
    $("#parts1").fadeTo("fast",0.8);
 
-
  });
 
-
  $("#parts1").mouseleave(function(){
 
-
    $("#parts1").fadeTo("fast", 1);
 
-
  });
 
-
  $("#safety1").mouseover(function(){
 
-
    $("#safety1").fadeTo("fast",0.9);
 
-
  });
 
-
  $("#safety1").mouseleave(function(){
 
-
    $("#safety1").fadeTo("fast", 1);
 
-
  });
 
   $('#menubar').mouseover(function(){
   $('#menubar').mouseover(function(){
     $('#menubar').stop().animate({top:"0px"},500);
     $('#menubar').stop().animate({top:"0px"},500);
Line 72: Line 43:
});
});
</script>
</script>
 +
<style type="text/css">
 +
body{background-color:#494042;width:100%;margin-bottom:20px;min-width:600px;max-width:2000px;height:100%;}
 +
#menubar
 +
{background-color:#EEECEC;opacity:0.8;top:-4px;width:360px;height:23px;position:absolute;top:-20px;}
 +
#menubar ul li a
 +
{ color:#8D1919;}
 +
#menubar.right-menu
 +
{background-color:#EEECEC;opacity:0.8;top:-4px;width:240px;height:23px;position:absolute;top:-20px;}
 +
.right-menu li a
 +
{color:#8D1919;background-color:#EEECEC;}
 +
#p-logo
 +
{visibility:hidden;}
 +
.firstHeading
 +
{visibility:hidden;}
 +
#globalWrapper
 +
{position: relative;font-size:127%;width:100%;margin:0;padding:0;padding-bottom:10px;background-color:#494042;}
 +
#content
 +
{width: 1000px;border:none;background-color:#494042;padding:0px;margin-top:0px;line-height: 1.5em;color: black;}
 +
#top-section
 +
{height:2px;border:none;background-color:#494042;}
 +
#catlinks
 +
{border-color:#494042;background-color:#494042;}
 +
#footer-box
 +
{display:none}
 +
#kepala
 +
{position:absolute;top:15px;background-color:#F0A5BE;height:121px;width:100%;}
 +
#Slideshow
 +
{
 +
position:absolute;
 +
left:30px;
 +
top:140px;
 +
}
-
<script type="text/javascript" src="http://ajax.googleapis.com/ajax/libs/jquery/1.3.2/jquery.min.js"></script>
+
#bar
-
<script type="text/javascript" src="https://static.igem.org/mediawiki/2013/archive/9/91/20130919145948%21Slide_Show.txt"></script>
+
{position:absolute;top:720px;background-color:#494042;height:121px;width:100%;}
 +
table.curvedEdges { border:10px solid #f4dfc0 ;-webkit-border-radius:10px;-moz-border-radius:13px;-ms-border-radius:13px;-o-border-radius:13px;border-radius:13px; }
-
<script type="text/javascript">
+
#copyright
 +
{position:absolute;left:300px;top:200px;}
-
$(function(){
 
-
 
-
$("#Slideshow").infiniteCarousel();
 
-
 
-
});
 
-
 
-
</script>
 
-
 
-
 
-
<style type="text/css">
 
.menu ul,li
.menu ul,li
{
{
Line 100: Line 95:
{
{
float:left;
float:left;
-
width:16.6667%;
+
width:16.66%;
}
}
ul.first>li>a:link,ul.first>li>a:visited
ul.first>li>a:link,ul.first>li>a:visited
Line 148: Line 143:
width:100%;
width:100%;
}
}
-
body{background-color:#494042;width:100%;margin-bottom:20px;min-width:600px;max-width:2000px;height:100%;}
+
ul, ol {
-
#team1
+
line-height: 1.6;
-
{position:absolute;top:141px;}
+
font-size: 14px;
-
#team2
+
}
-
{position:absolute;top:141px;}
+
#slide{width:96%;height:auto;background-color:#F4DFC0;margin-top:80px;border:2px solid;
-
#wetlab1
+
border-radius:15px;padding-right:10px;margin-left:15px;}
-
{position:absolute;top:321px;}
+
.center
-
#wetlab2
+
-
{position:absolute;top:321px;}
+
-
#achieve1
+
-
{position:absolute;left:227px;top:476px;}
+
-
#achieve2
+
-
{position:absolute;left:227px;top:476px;}
+
-
#hp1
+
-
{position:absolute;left:453px;top:476px;}
+
-
#hp2
+
-
{position:absolute;left:453px;top:476px;}
+
-
#parts1
+
-
{position:absolute;left:890px;top:366px;}
+
-
#parts2
+
-
{position:absolute;left:890px;top:366px;}
+
-
#safety1
+
-
{position:absolute;left:780px;top:366px;}
+
-
#safety2
+
-
{position:absolute;left:780px;top:366px;}
+
-
#project1
+
-
{position:absolute;left:780px;top:141px;}
+
-
#project2
+
-
{position:absolute;left:780px;top:141px;}
+
-
#menubar
+
-
{background-color:#EEECEC;opacity:0.8;top:-4px;width:360px;height:23px;position:absolute;top:-20px;}
+
-
#menubar ul li a
+
-
{ color:#8D1919;}
+
-
#menubar.right-menu
+
-
{background-color:#EEECEC;opacity:0.8;top:-4px;width:240px;height:23px;position:absolute;top:-20px;}
+
-
.right-menu li a
+
-
{color:#8D1919;background-color:#EEECEC;}
+
-
#p-logo
+
-
{visibility:hidden;}
+
-
.firstHeading
+
-
{visibility:hidden;}
+
-
#globalWrapper
+
-
{position: relative;font-size:127%;width:100%;margin:0;padding:0;padding-bottom:10px;background-color:#494042;}
+
-
#content
+
-
{width: 1000px;border:none;background-color:#494042;padding:0px;margin-top:0px;}
+
-
#top-section
+
-
{height:2px;border:none;background-color:#494042;}
+
-
#catlinks
+
-
{border-color:#494042;background-color:#494042;}
+
-
#footer-box
+
-
{display:none}
+
-
#kepala
+
-
{position:absolute;top:15px;background-color:#F0A5BE;}
+
-
#copyright
+
-
{position:absolute;left:325px;top:830px;}
+
-
 
+
-
#bar
+
-
{position:absolute;top:630px;background-color:#494042;height:121px;width:100%;}
+
-
table.curvedEdges { border:10px solid #f4dfc0 ;-webkit-border-radius:20px;-moz-border-radius:13px;-ms-border-radius:13px;-o-border-radius:13px;border-radius:13px; }
+
-
 
+
-
 
+
-
#Slideshow
+
{
{
-
position:absolute;
+
margin:auto;
-
left:225px;
+
width:70%;
-
top:0px;
+
background-color:#b0e0e6;
}
}
 +
#interview,#presentation,#article, #interview1, #presentation1,#article1
 +
{margin-top:100px;width:15%;margin-right:5px;float:left;height:145px; border:2px solid;
 +
border-radius:15px;font-family:"Trebuchet MS", Helvetica, sans-serif;}
 +
 +
#interview
 +
{margin-left:25px;background:#35bb91;}
 +
#interview1
 +
{margin-left:0px;background:#e32e51;}
 +
#presentation,#article1
 +
{background:#e32e51;}
 +
#article,#presentation1
 +
{background:#35bb91;}
 +
#art-desc,#pre-desc,#int-desc{width:50%;float:right;margin-right:8px;}
 +
#art-img,#pre-img,#int-img{width:45%;float:left;margin-left:5px;}
 +
#art-desc-text,#pre-desc-text,#int-desc-text{float:right;}
 +
h3,h1,#yo{margin-left:10px;font-family:"Trebuchet MS", Helvetica, sans-serif;}
 +
h1{font-size:35px;}
</style>
</style>
</head>
</head>
-
 
<body>
<body>
 +
<div id="Slideshow">
 +
<ul>
 +
<li>
 +
        <img src="https://static.igem.org/mediawiki/2013/c/ce/Slideshow1.jpg" width="550" height="330" />
 +
              <p>Worldwide obesity has nearly doubled since 1980, while in 2008, more than 1.4 billion adults, 20 and older, were overweight.              In particular, many low- and middle-income countries face “double burden” of under-nutrition and obesity. Rates of malnutrition is much higher in low income countries, while there is a greater exposure to high-sugar, high-fat, high-salt foods which are low in cost and nutrients. Such dietary patterns result in low levels of physical strength and sharp increase in childhood obesity with under-nutrition existing side-by-side.
 +
</p>
 +
        </li>
 +
        <li>
 +
        <img src="https://static.igem.org/mediawiki/2013/e/ea/Slideshow2.jpg" width="550" height="330" />
 +
            <p>2. In obesity, fatty acids delivered to liver may outpace fatty acid oxidation in hepatocytes, resulting in triglyceride accumulation. Obesity leads to health hazards, including cardiovascular disease - mainly heart disease and stroke, diabetes, musculoskeletal disorders, especially osteoarthritis – a highly disabling degenerative disease of the joints, and cancers, such as endometrial, breast and colon cancers.
 +
 +
Combined: http://www.healthcentral.com/common/images/1/19473_13187_5.jpg
 +
Cardiovascular: Obesity and other health conditions associated with obesity, including hypertension, insulin resistance, diabetes and hyperlipidemia, are risk factors of cardiovascular disease.
 +
http://www.beltina.org/health-dictionary/obesity-cardiovascular-disease-bmi-table.html
 +
Diabetes: Patients with type 2 diabetes are insulin resistant, in which high levels of blood fats, cholesterol and triglyceride levels inhibit cells from absorbing blood sugar needed.
 +
http://www.bubblews.com/news/560642-cause-of-type-2-diabetes
 +
Musculoskeletal disorders: Those with a body mass index (BMI) greater than 26.4 had rate of osteoarthritis of the knees 6 times greater than those with a body mass index of less than 23.4. (Ref. J. Rheumatol. 20 (2) 331-5)
 +
http://pharmaworlds.com/obesity-a-growing-burden-for-physicians-and-patients/
 +
 +
 +
</p>
 +
 +
        </li>
 +
<li>
 +
        <img src="https://static.igem.org/mediawiki/2013/d/db/Slideshow3.jpg" width="550" height="330" />
 +
<p>The fundamental cause of obesity is an energy imbalance between calories consumed and expended. To increase expenditure of fatty acids (calories), HKUST 2013 Team aims to introduce glyoxylate shunt as an artificial futile cycle in HepG2 cell.</p>                   
 +
</li>
 +
     
 +
        <li>
 +
        <img src="https://static.igem.org/mediawiki/2013/d/db/Slideshow4.jpg" width="550" height="330" />
 +
          <p>Part 1 Sense Fatty Acids: We investigated four different sensing mechanisms using: 1) fatty acid metabolism regulator protein (FadR), 2) peroxisome proliferator-activated receptor-alpha (PPAR-alpha) 3) liver- fatty acid binding protein (FABP1) and 4) binding immunoglobulin protein, HSP5 or glucose regulated protein (GRP78). The four sensing mechanisms were measured and compared. </p>
 +
        </li>
 +
          <li>
 +
        <img src="https://static.igem.org/mediawiki/2013/d/d0/Slideshow5.jpg" width="550" height="330" />
 +
          <p>Part 2 Introduce Glyoxylate Shunt: We introduced two key enzymes of glyoxylate cycle: isocitrate lyase (ACEA) and malate synthase (ACEB), which allow plants and bacteria to use fatty acids as a substrate for gluconeogenesis. Here, the amount of fatty acids was measured to compare fatty acids uptake rates of cells expressing glyoxylate shunt.</p>
 +
 +
        </li>
 +
        <li>
 +
        <img src="https://static.igem.org/mediawiki/2013/2/2c/Slideshow6.jpg" width="550" height="330" />
 +
          <p>Integration of Parts: The integration of sensing mechanism and glyoxylate shunt allows inducible glyoxylate shunt, in which the high levels of free fatty acids in the medium increase fatty acid uptake rate of glyoxylate shunt. </p>
 +
        </li>
 +
  <li>
 +
        <img src="https://static.igem.org/mediawiki/2013/f/f5/Slideshow7.jpg" width="550" height="330" />
 +
          <p>Although the problem of malnutrition may remain unsolved, the inducible glyoxylate shunt introduced to mammalian cell increases consumption of fatty acids, lowering the risk of excessive fat accumulation that presents risk to health.</p>
 +
        </li>
 +
</ul>
 +
</div>
 +
 +
<a href=https://2013.igem.org/Team:Hong_Kong_HKUST><center><div id="kepala"><img src="https://static.igem.org/mediawiki/igem.org/c/c7/BANNER1_%281%29.png" style="height:121px;width:100%;"></div></center></a>
<div class="menu">
<div class="menu">
Line 278: Line 283:
</div>
</div>
-
<h3><center><div id="kepala" style="height:121px;width:100%;"><img src="https://static.igem.org/mediawiki/igem.org/c/c7/BANNER1_%281%29.png" style="height:121px;width:100%;align:middle;"></div></center></h3>
+
<br><br><br>
-
<div id="Slideshow">
+
<div id="interview"><center><h3>Characterization</h3></center>
-
<ul>
+
<div id="int-img"><center><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/interview">
-
<li>
+
<img src="https://static.igem.org/mediawiki/2013/1/17/Wetlab2.png" style="width:100%;padding-left:30px;"></a></center></div>
-
        <img src="https://static.igem.org/mediawiki/2013/c/ce/Slideshow1.jpg" width="550" height="330" />
+
</div>
-
              <p>Worldwide obesity has nearly doubled since 1980, while in 2008, more than 1.4 billion adults, 20 and older, were overweight.              In particular, many low- and middle-income countries face “double burden” of under-nutrition and obesity. Rates of malnutrition is much higher in low income countries, while there is a greater exposure to high-sugar, high-fat, high-salt foods which are low in cost and nutrients. Such dietary patterns result in low levels of physical strength and sharp increase in childhood obesity with under-nutrition existing side-by-side.
+
-
</p>
+
-
        </li>
+
-
        <li>
+
-
        <img src="https://static.igem.org/mediawiki/2013/e/ea/Slideshow2.jpg" width="550" height="330" />
+
-
            <p>2. In obesity, fatty acids delivered to liver may outpace fatty acid oxidation in hepatocytes, resulting in triglyceride accumulation. Obesity leads to health hazards, including cardiovascular disease - mainly heart disease and stroke, diabetes, musculoskeletal disorders, especially osteoarthritis – a highly disabling degenerative disease of the joints, and cancers, such as endometrial, breast and colon cancers.
+
-
Combined: http://www.healthcentral.com/common/images/1/19473_13187_5.jpg
+
<div id="presentation"><center><h3>Parts</h3></center>
-
Cardiovascular: Obesity and other health conditions associated with obesity, including hypertension, insulin resistance, diabetes and hyperlipidemia, are risk factors of cardiovascular disease.
+
<div id="pre-img"><center><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/presentation">
-
http://www.beltina.org/health-dictionary/obesity-cardiovascular-disease-bmi-table.html
+
<img src="https://static.igem.org/mediawiki/2013/1/17/Wetlab2.png" style="width:100%;padding-left:30px;"></a></center></div></div>
-
Diabetes: Patients with type 2 diabetes are insulin resistant, in which high levels of blood fats, cholesterol and triglyceride levels inhibit cells from absorbing blood sugar needed.
+
-
http://www.bubblews.com/news/560642-cause-of-type-2-diabetes
+
-
Musculoskeletal disorders: Those with a body mass index (BMI) greater than 26.4 had rate of osteoarthritis of the knees 6 times greater than those with a body mass index of less than 23.4. (Ref. J. Rheumatol. 20 (2) 331-5)
+
-
http://pharmaworlds.com/obesity-a-growing-burden-for-physicians-and-patients/
+
 +
<div id="article"><center><h3>Human Practice</h3></center>
 +
<div id="art-img"><center><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/article/genet">
 +
<img src="https://static.igem.org/mediawiki/2013/5/55/Hp2.png" style="width:85%;padding-left:40px;"></a></center></div></div>
-
</p>
+
<div id="interview1"><center><h3>Data</h3></center>
 +
<div id="int-img"><center><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/video">
 +
<img src="https://static.igem.org/mediawiki/2013/1/17/Wetlab2.png" style="width:100%;padding-left:30px;"></a></center></div></div>
-
        </li>
+
<div id="presentation1"><center><h3>Project</h3></center>
-
<li>
+
<div id="pre-img"><center><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/cp">
-
        <img src="https://static.igem.org/mediawiki/2013/d/db/Slideshow3.jpg" width="550" height="330" />
+
<img src="https://static.igem.org/mediawiki/2013/f/f9/Project2.png" style="width:80%;padding-left:40px;"></a></center></div></div>
-
<p>The fundamental cause of obesity is an energy imbalance between calories consumed and expended. To increase expenditure of fatty acids (calories), HKUST 2013 Team aims to introduce glyoxylate shunt as an artificial futile cycle in HepG2 cell.</p>                  
+
-
</li>
+
-
     
+
-
        <li>
+
-
        <img src="https://static.igem.org/mediawiki/2013/d/db/Slideshow4.jpg" width="550" height="330" />
+
-
          <p>Part 1 Sense Fatty Acids: We investigated four different sensing mechanisms using: 1) fatty acid metabolism regulator protein (FadR), 2) peroxisome proliferator-activated receptor-alpha (PPAR-alpha) 3) liver- fatty acid binding protein (FABP1) and 4) binding immunoglobulin protein, HSP5 or glucose regulated protein (GRP78). The four sensing mechanisms were measured and compared. </p>
+
-
        </li>
+
-
          <li>
+
-
        <img src="https://static.igem.org/mediawiki/2013/d/d0/Slideshow5.jpg" width="550" height="330" />
+
-
          <p>Part 2 Introduce Glyoxylate Shunt: We introduced two key enzymes of glyoxylate cycle: isocitrate lyase (ACEA) and malate synthase (ACEB), which allow plants and bacteria to use fatty acids as a substrate for gluconeogenesis. Here, the amount of fatty acids was measured to compare fatty acids uptake rates of cells expressing glyoxylate shunt.</p>
+
-
        </li>
+
<div id="article1"><center><h3>Achievement</h3></center>
-
        <li>
+
<div id="art-img"><center><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/blog">
-
        <img src="https://static.igem.org/mediawiki/2013/2/2c/Slideshow6.jpg" width="550" height="330" />
+
<img src="https://static.igem.org/mediawiki/2013/1/17/Wetlab2.png" style="width:100%;padding-left:30px;"></a></center></div></div>
-
          <p>Integration of Parts: The integration of sensing mechanism and glyoxylate shunt allows inducible glyoxylate shunt, in which the high levels of free fatty acids in the medium increase fatty acid uptake rate of glyoxylate shunt. </p>
+
-
        </li>
+
-
  <li>
+
-
        <img src="https://static.igem.org/mediawiki/2013/f/f5/Slideshow7.jpg" width="550" height="330" />
+
-
          <p>Although the problem of malnutrition may remain unsolved, the inducible glyoxylate shunt introduced to mammalian cell increases consumption of fatty acids, lowering the risk of excessive fat accumulation that presents risk to health.</p>
+
-
        </li>
+
-
</ul>
+
-
</div>
+
-
<div id="team2" style="background:#ffffff;height:175px;width:22%;"></div>
 
-
<a href=https://2013.igem.org/Team:Hong_Kong_HKUST/team><div id="team1" style="background:#e32e51;height:175px;width:22%;"><br>
 
-
<center><img src="https://static.igem.org/mediawiki/2013/archive/e/e4/20130802032024%21Team2.png" style="height:100px;width:140px;align:middle;"><br><br><img src="https://static.igem.org/mediawiki/2013/0/00/Team0.png" style="height:40px;width:65px;align:middle;"></center></div></a>
 
-
<div id="wetlab2" style="background:#ffffff;height:295px;width:22%;"></div>
 
-
 
-
<div id="wetlab1" style="background:#35bb91;height:295px;width:22%;"><a href=https://2013.igem.org/Team:Hong_Kong_HKUST/Wetlab><br><br><br><center><img src="https://static.igem.org/mediawiki/2013/1/17/Wetlab2.png" style="height:120px;width:90px;"><br><br><br><img src="https://static.igem.org/mediawiki/2013/1/18/Wetlab0.png" style="height:40px;width:80px;"></center></a></div>
 
-
 
-
<div id="achieve2" style="background:#ffffff;height:140px;width:22%;"></div>
 
-
<a href=https://2013.igem.org/Team:Hong_Kong_HKUST/achievement><div id="achieve1" style="background:#e32e51;height:140px;width:22%;"><center><br><img src="https://static.igem.org/mediawiki/2013/1/1e/Achievement2.png" style="height:110px;width:75px;"><img src="https://static.igem.org/mediawiki/2013/e/e3/Achievement0.png" style="height:40px;width:120px;align:middle;"></center>
 
-
</div></a>
 
-
<div id="hp2" style="background:#ffffff;height:140px;width:43.1%;">
 
-
</div>
 
-
<a href=https://2013.igem.org/Team:Hong_Kong_HKUST/hp><div id="hp1" style="background:#35bb91;height:140px;width:43.1%;"><center><br><img src="https://static.igem.org/mediawiki/2013/5/55/Hp2.png" style="height:110px;width:75px;"><img src="https://static.igem.org/mediawiki/2013/4/4c/Hp0.png" style="height:40px;width:150px;">
 
-
</center>
 
-
</div></a>
 
-
<div id="parts2" style="background:#ffffff;height:250px;width:11%;"></div>
 
-
<a href=https://2013.igem.org/Team:Hong_Kong_HKUST/Parts><div id="parts1" style="background:#b9b2a0;height:250px;width:11%;"><br><br><br><br><center><img src="https://static.igem.org/mediawiki/2013/e/e6/Parts2.png" style="height:100px;width:60px;align:middle;"><br><br><img src="https://static.igem.org/mediawiki/2013/a/a6/Parts0.png" style="height:30px;width:50px;align:middle;"></a>
 
-
</div></a>
 
-
<div id="safety2" style="background:#ffffff;height:105px;width:10.5%;"></div>
 
-
<a href=https://2013.igem.org/Team:Hong_Kong_HKUST/safety><div id="safety1" style="background:#e32e51;height:105px;width:10.5%;"><center><img src="https://static.igem.org/mediawiki/2013/6/67/Safety2.png" style="height:55px;width:55px;align:middle;padding-top:10px;"><br>
 
-
<img src="https://static.igem.org/mediawiki/2013/0/07/Safety0.png" style="height:30px;width:50px;align:middle;"></center>
 
-
</div></a>
 
-
<div id="project2" style="background:#ffffff;height:220px;width:22%;">
 
-
</div>
 
-
<a href=https://2013.igem.org/Team:Hong_Kong_HKUST/Project><div id="project1" style="background:#35bb91;height:220px;width:22%;"><br>
 
-
<center><br><img src="https://static.igem.org/mediawiki/2013/f/f9/Project2.png" style="height:120px;width:60px;align:middle;"><br><br><img src="https://static.igem.org/mediawiki/2013/2/28/Projects0.png" style="height:40px;width:80px;align:middle;"></center>
 
-
</div></a>
 
-
<div id="copyright"><center><p style="font-size:14px;font-family:century gothic;font-colour:#ffffff;"> © Copyright HKUST iGEM Team 2013, All Rights Reserved</p></center></div>
 
Line 366: Line 320:
<col width="13%">
<col width="13%">
  <tr align="left" valign="middle">
  <tr align="left" valign="middle">
-
     <td valign="baseline" nowrap bgcolor="#f4dfc0"><ul>
+
     <td valign="baseline" bgcolor="#f4dfc0"><ul>
       <li><strong><a href="https://2013.igem.org/Team:Hong_Kong_HKUST">Home</a></strong></li>
       <li><strong><a href="https://2013.igem.org/Team:Hong_Kong_HKUST">Home</a></strong></li>
     </ul>
     </ul>
Line 418: Line 372:
</table>
</table>
 +
<div id="copyright"><center><p style="font-size:14px;font-family:century gothic;font-colour:#ffffff;"> © Copyright HKUST iGEM Team 2013, All Rights Reserved</p></center></div>
</body>
</body>
-
 
</html>
</html>

Revision as of 17:40, 25 September 2013

  • Worldwide obesity has nearly doubled since 1980, while in 2008, more than 1.4 billion adults, 20 and older, were overweight. In particular, many low- and middle-income countries face “double burden” of under-nutrition and obesity. Rates of malnutrition is much higher in low income countries, while there is a greater exposure to high-sugar, high-fat, high-salt foods which are low in cost and nutrients. Such dietary patterns result in low levels of physical strength and sharp increase in childhood obesity with under-nutrition existing side-by-side.

  • 2. In obesity, fatty acids delivered to liver may outpace fatty acid oxidation in hepatocytes, resulting in triglyceride accumulation. Obesity leads to health hazards, including cardiovascular disease - mainly heart disease and stroke, diabetes, musculoskeletal disorders, especially osteoarthritis – a highly disabling degenerative disease of the joints, and cancers, such as endometrial, breast and colon cancers. Combined: http://www.healthcentral.com/common/images/1/19473_13187_5.jpg Cardiovascular: Obesity and other health conditions associated with obesity, including hypertension, insulin resistance, diabetes and hyperlipidemia, are risk factors of cardiovascular disease. http://www.beltina.org/health-dictionary/obesity-cardiovascular-disease-bmi-table.html Diabetes: Patients with type 2 diabetes are insulin resistant, in which high levels of blood fats, cholesterol and triglyceride levels inhibit cells from absorbing blood sugar needed. http://www.bubblews.com/news/560642-cause-of-type-2-diabetes Musculoskeletal disorders: Those with a body mass index (BMI) greater than 26.4 had rate of osteoarthritis of the knees 6 times greater than those with a body mass index of less than 23.4. (Ref. J. Rheumatol. 20 (2) 331-5) http://pharmaworlds.com/obesity-a-growing-burden-for-physicians-and-patients/

  • The fundamental cause of obesity is an energy imbalance between calories consumed and expended. To increase expenditure of fatty acids (calories), HKUST 2013 Team aims to introduce glyoxylate shunt as an artificial futile cycle in HepG2 cell.

  • Part 1 Sense Fatty Acids: We investigated four different sensing mechanisms using: 1) fatty acid metabolism regulator protein (FadR), 2) peroxisome proliferator-activated receptor-alpha (PPAR-alpha) 3) liver- fatty acid binding protein (FABP1) and 4) binding immunoglobulin protein, HSP5 or glucose regulated protein (GRP78). The four sensing mechanisms were measured and compared.

  • Part 2 Introduce Glyoxylate Shunt: We introduced two key enzymes of glyoxylate cycle: isocitrate lyase (ACEA) and malate synthase (ACEB), which allow plants and bacteria to use fatty acids as a substrate for gluconeogenesis. Here, the amount of fatty acids was measured to compare fatty acids uptake rates of cells expressing glyoxylate shunt.

  • Integration of Parts: The integration of sensing mechanism and glyoxylate shunt allows inducible glyoxylate shunt, in which the high levels of free fatty acids in the medium increase fatty acid uptake rate of glyoxylate shunt.

  • Although the problem of malnutrition may remain unsolved, the inducible glyoxylate shunt introduced to mammalian cell increases consumption of fatty acids, lowering the risk of excessive fat accumulation that presents risk to health.



Characterization

Parts

Human Practice

Data

Project

Achievement